Iodine-131-tositumomab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Iodine-131-tositumomab, covering 2012-03-13 to 2018-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma